Opioid- and Stimulant-related Harms in Canada Published: (September 2023): Health Infobase
This update is based on data submitted to the Public Health Agency of Canada on or before February 1, 2023. Due to differences in identifying and reporting cases, comparisons over time and between provinces and territories should be interpreted with caution. Refer to the Technical Notes for more information.
Region | Crude rate |
---|---|
2023 (Jan to Mar) - Canada | 20.3 |
2023 (Jan to Mar) - British Columbia | 48.1 |
2023 (Jan to Mar) - Alberta | 38.2 |
2023 (Jan to Mar) - Saskatchewan | 13.1 |
2023 (Jan to Mar) - Manitoba | Not available |
2023 (Jan to Mar) - Ontario | 17.0 |
2023 (Jan to Mar) - Quebec | 5.1 |
2023 (Jan to Mar) - New Brunswick | 5.4 |
2023 (Jan to Mar) - Nova Scotia | 5.9 |
2023 (Jan to Mar) - Prince Edward Island | 4.7 |
2023 (Jan to Mar) - Newfoundland and Labrador | 6.8 |
2023 (Jan to Mar) - Yukon | 27.4 |
2023 (Jan to Mar) - Northwest Territories | 0.0 |
2023 (Jan to Mar) - Nunavut | 0.0 |
Acknowledgments
This update would not be possible without the collaboration and dedication of provincial and territorial (PT) offices of Chief Coroners and Chief Medical Examiners as well as PT public health and health partners and Emergency Medical Services data providers. We would also like to acknowledge the Canadian Institute for Health Information (CIHI) for collecting and providing the data used for reporting opioid- and stimulant-related poisoning hospitalizations.
Suggested Citation
Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-related Harms in Canada. Ottawa: Public Health Agency of Canada; September 2023. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/